Innoviva, Inc. (INVA)
Collects royalties from respiratory and antibiotic medications sold worldwide.
$21.81+0.02%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+17.1%
The outlook
INVA trades at $21.81, roughly midway through its 52-week range with mixed positioning against key moving averages. Analyst coverage shows a notably bullish lean, with an average price target around 63% above current levels, while the stock's 3.5 trailing P/E sits well below typical market averages.
What’s behind the score
Price trendMixed vs its moving averages
52-week range61% of the way from its 52-week low to high
Price targetAvg target +63% vs current price
Analyst price target
~12-month · 4 analysts$35.50average target+62.8% vs now
Now $21.81
Low $18.00High $46.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.61B
52-wk high
$25.15
52-wk low
$16.52
50-day avg
$22.23
200-day avg
$21.44
Trailing P/E
3.5